Molecular basis for membrane pore formation by Bax protein carboxyl terminus.
Molecular basis for membrane pore formation by Bax protein carboxyl terminus.
复制标题
Bax 蛋白羧基末端形成膜孔的分子基础。
DOI:
10.1021/bi301195f
复制
发表时间:
2012
期刊:
影响因子:
2.9
通讯作者:
Khaled,AnnetteR
中科院分区:
文献类型:
--
作者:
Tatulian,SurenA;Garg,Pranav;Nemec,KathleenN;Chen,Bo;Khaled,AnnetteR
Bax protein plays a key role in mitochondrial membrane permeabilization and cytochrome c release upon apoptosis. There is compelling evidence that the C-terminal peptide of Bax has strong capability of forming pores in lipid membranes. Moreover, our recent data have indicated that the intracellularly expressed peptide translocates to the mitochondria and exerts lethal effect on cancer cells, identifying the C-terminal peptide of Bax as a potential cytotoxic agent. We have shown that the C-terminal 20-amino acid stretch of Bax (BaxC-KK; VTIFVAGVLTASLTIWKKMG), as well as two mutants where the two lysines are replaced with glutamate (BaxC-EE) or leucine (BaxC-LL), form relatively large pores in lipid membranes. The pore structure is analyzed by polarized Fourier transform infrared, circular dichroism, and fluorescence experiments on the peptides reconstituted in phospholipid membranes. The peptides assume an α/β-type secondary structure within membranes. Both β-strands and α-helices are significantly (by 30-60 degrees) tilted relative to the membrane normal. The tryptophan residue embeds into zwitterionic membranes at 8-9 Å from membrane center. Membrane anionic charge causes a deeper insertion of tryptophan for BaxC-KK and BaxC-LL but not BaxC-EE. Combined with pore stoichiometry determined based on the kinetics of calcein release from lipid vesicles, these structural constraints allow construction of a model of the pore where eight peptide molecules form an “α/β-ring” structure with pore inner diameter of 20-22 Å. These results identify a strong membranotropic activity of Bax C-terminus and propose a new mechanism by which peptides can efficiently perforate cell membranes. Knowledge on the pore forming mechanism of the peptide may facilitate development of peptide-based therapies to kill cancer or other detrimental cells such as bacteria or fungi.